Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Colorado, Denver
Age
18–55
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
18-55 inclusive years of age at the time of informed consent
Diagnosis of relapsing multiple sclerosis as defined by the 2010 revised McDonald criteria
Currently taking Tysabri
You may not be if
Systemic steroid users
comorbidities that could confound MRI outcomes
Clareo Health | Does Long-Term Natalizumab (NTZ) Therapy Normalize Brain Atrophy Rates and Quality of Life (QOL) in Relapsing Remitting Multiple Sclerosis (RRMS)?
